BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33782133)

  • 1. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.
    Chapman NS; Zhao H; Kose N; Westover JB; Kalveram B; Bombardi R; Rodriguez J; Sutton R; Genualdi J; LaBeaud AD; Mutuku FM; Pittman PR; Freiberg AN; Gowen BB; Fremont DH; Crowe JE
    Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33782133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus.
    Wang Q; Ma T; Wu Y; Chen Z; Zeng H; Tong Z; Gao F; Qi J; Zhao Z; Chai Y; Yang H; Wong G; Bi Y; Wu L; Shi R; Yang M; Song J; Jiang H; An Z; Wang J; Yilma TD; Shi Y; Liu WJ; Liang M; Qin C; Gao GF; Yan J
    Nat Microbiol; 2019 Jul; 4(7):1231-1241. PubMed ID: 30936489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus.
    Allen ER; Krumm SA; Raghwani J; Halldorsson S; Elliott A; Graham VA; Koudriakova E; Harlos K; Wright D; Warimwe GM; Brennan B; Huiskonen JT; Dowall SD; Elliott RM; Pybus OG; Burton DR; Hewson R; Doores KJ; Bowden TA
    Cell Rep; 2018 Dec; 25(13):3750-3758.e4. PubMed ID: 30590046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein.
    Hao M; Zhang G; Zhang S; Chen Z; Chi X; Dong Y; Fan P; Liu Y; Chen Y; Song X; Liu S; Yu C; Li J; Xia X
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32120864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc.
    Jäckel S; Eiden M; Dauber M; Balkema-Buschmann A; Brun A; Groschup MH
    Arch Virol; 2014 Mar; 159(3):535-46. PubMed ID: 24100475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
    López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
    PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection
    Cartwright HN; Barbeau DJ; McElroy AK
    mSphere; 2021 Oct; 6(5):e0055621. PubMed ID: 34494884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
    Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
    Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
    Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
    Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
    Cairns TM; Fontana J; Huang ZY; Whitbeck JC; Atanasiu D; Rao S; Shelly SS; Lou H; Ponce de Leon M; Steven AC; Eisenberg RJ; Cohen GH
    J Virol; 2014 Mar; 88(5):2677-89. PubMed ID: 24352457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production.
    Bracci N; de la Fuente C; Saleem S; Pinkham C; Narayanan A; García-Sastre A; Balaraman V; Richt JA; Wilson W; Kehn-Hall K
    Virology; 2022 Feb; 567():65-76. PubMed ID: 35032865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.
    Tercero B; Narayanan K; Terasaki K; Makino S
    J Virol; 2021 Jun; 95(14):e0042921. PubMed ID: 33952635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope.
    Wu Y; Zhu Y; Gao F; Jiao Y; Oladejo BO; Chai Y; Bi Y; Lu S; Dong M; Zhang C; Huang G; Wong G; Li N; Zhang Y; Li Y; Feng WH; Shi Y; Liang M; Zhang R; Qi J; Gao GF
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7564-E7573. PubMed ID: 28827346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
    Bhardwaj N; Heise MT; Ross TM
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e725. PubMed ID: 20582312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
    Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins.
    Besselaar TG; Blackburn NK
    Arch Virol; 1992; 125(1-4):239-50. PubMed ID: 1642552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Quadruple Gene-Deleted BoHV-1-Vectored RVFV Subunit Vaccine Induces Humoral and Cell-Mediated Immune Response against Rift Valley Fever in Calves.
    Pavulraj S; Stout RW; Barras ED; Paulsen DB; Chowdhury SI
    Viruses; 2023 Oct; 15(11):. PubMed ID: 38005861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
    Gutjahr B; Keller M; Rissmann M; von Arnim F; Jäckel S; Reiche S; Ulrich R; Groschup MH; Eiden M
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008143. PubMed ID: 32160203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of monoclonal antibodies to Rift Valley Fever Virus and their application in antigen detection and indirect immunofluorescence.
    Mroz C; Schmidt KM; Reiche S; Groschup MH; Eiden M
    J Immunol Methods; 2018 Sep; 460():36-44. PubMed ID: 29894749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.